Literature DB >> 14236724

IMPLICATIONS OF LONG-TERM SURVIVAL IN ACUTE STEM CELL LEUKEMIA OF CHILDHOOD TREATED WITH COMPOSITE CYCLIC THERAPY.

W W ZUELZER.   

Abstract

Entities:  

Keywords:  CHILD; DRUG THERAPY; HYDROCORTISONE; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MONOCYTIC; LEUKEMIA, MYELOCYTIC; MERCAPTOPURINE; METHOTREXATE; PERIODICITY; PREDNISONE, THERAPEUTIC; PROGNOSIS; STATISTICS

Mesh：

Substances：

Year:  1964        PMID： 14236724

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  24 in total

1.  PROGRESS WITH CHILDHOOD LEUKAEMIA.

Authors:  C R PENGELLY
Journal:  Br Med J       Date:  1965-05-22

2.  THE CHEMOTHERAPY OF MALIGNANT DISEASE--PRACTICAL AND EXPERIMENTAL CONSIDERATIONS.

Authors:  J MATTHIAS
Journal:  Postgrad Med J       Date:  1965-05       Impact factor: 2.401

Review 3.  Optimizing treatment in paediatric rheumatology--lessons from oncology.

Authors:  Tim Niehues
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

4.  Acute leukemias in children.

Authors:  M K Pai
Journal:  Can Fam Physician       Date:  1979-09       Impact factor: 3.275

5.  Immunological cell markers on lymphoblasts of patients with acute lymphatic leukemia.

Authors:  H U Schwenk
Journal:  Z Kinderheilkd       Date:  1974

6.  Cyclic chemotherapy in acute lymphoblastic leukaemia of childhood: 5-year survivals.

Authors:  M R Vowels; M L Willoughby
Journal:  Arch Dis Child       Date:  1973-06       Impact factor: 3.791

7.  Better results in childhood acute leukemia.

Authors: 
Journal:  Br Med J       Date:  1973-06-16

8.  Meningeal leukaemia.

Authors:  R M Hardisty; P M Norman
Journal:  Arch Dis Child       Date:  1967-08       Impact factor: 3.791

Review 9.  Chemotherapy of acute leukemia in childhood.

Authors:  K K Khanna
Journal:  Indian J Pediatr       Date:  1968-12       Impact factor: 1.967

10.  Discontinuing therapy in childhood acute lymphoblastic leukemia treated with a chemoimmunotherapy protocol.

Authors:  Y Komada; E Azuma; H Yamamoto; S Tanaka; K Shimizu; H Kamiya; M Sakurai; T Izawa
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.